InsiderTrades.com logo
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol

ATNF Insider Trading

Insider Ownership Percentage: 0.17%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

180 Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at 180 Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

180 Life Sciences Share Price & Price History

Current Price: $1.86
Price Change: ▼ Price Decrease of -0.08 (-4.12%)
As of 12/20/2024 06:45 PM ET

This chart shows the closing price history over time for ATNF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.

180 Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/31/2023Donald A. McGovern, Jr.DirectorBuy526$21.85$11,493.101,584View SEC Filing Icon  
5/18/2023James N. WoodyCEOBuy2,105$19.57$41,194.852,204View SEC Filing Icon  
5/18/2023Ozan PamirCFOBuy271$19.19$5,200.49472View SEC Filing Icon  
5/18/2023Pamela G MarroneDirectorBuy372$20.14$7,492.08656View SEC Filing Icon  
See Full Table
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for 180 Life Sciences (NASDAQ:ATNF)

4.07% of 180 Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ATNF by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

180 Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC131,000$80K0.0%N/A2.462%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC3,915,000$2.60M0.0%N/A11.466%Search for SEC Filing on Google Icon
2/10/2022Citizens Financial Group Inc RI131,775$0.51M0.0%N/A0.387%Search for SEC Filing on Google Icon
2/10/2022Rathbones Group PLC50,000$0.20M0.0%N/A0.147%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.240,813$1.30M0.0%-9.5%0.718%Search for SEC Filing on Google Icon
11/5/2021First National Trust Co19,000$0.10M0.0%N/A0.057%Search for SEC Filing on Google Icon
10/19/2021Belvedere Trading LLC51,544$0.31M0.0%-23.5%0.153%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC25,495$0.26M0.0%-13.2%0.076%Search for SEC Filing on Google Icon
9/7/2021Newbridge Financial Services Group Inc.3,000$30K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP12,100$0.12M0.0%+119.6%0.039%Search for SEC Filing on Google Icon
8/16/2021State Street Corp63,426$0.63M0.0%N/A0.206%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp29,068$0.29M0.0%+13.4%0.094%Search for SEC Filing on Google Icon
8/13/2021Murchinson Ltd.95,276$0.95M0.3%N/A0.310%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC123,049$1.23M0.0%-5.9%0.400%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.390,260$3.90M0.0%-22.2%1.268%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.266,016$2.66M0.0%+3.3%0.865%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC29,372$0.19M0.0%N/A0.163%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP17,590$0.12M0.0%N/A0.098%Search for SEC Filing on Google Icon
5/17/2021Pinz Capital Management LP5,510$36K0.0%N/A0.031%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG10,300$68K0.0%N/A0.057%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC130,695$0.86M0.0%N/A0.725%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.257,396$1.69M0.0%N/A1.427%Search for SEC Filing on Google Icon
5/6/2021First National Trust Co12,000$79K0.0%N/A0.067%Search for SEC Filing on Google Icon
4/28/2021Mizuho Securities USA LLC52,400$0.34M0.0%N/A0.291%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
180 Life Sciences logo
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Read More on 180 Life Sciences

Today's Range

Now: $1.86
Low: $1.86
High: $2.02

50 Day Range

MA: $2.88
Low: $1.36
High: $6.47

52 Week Range

Now: $1.86
Low: $1.16
High: $17.75

Volume

52,501 shs

Average Volume

732,560 shs

Market Capitalization

$1.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of 180 Life Sciences?

180 Life Sciences' top insider investors include:
  1. James N Woody (CEO)
  2. Jr Donald A Mcgovern (Director)
  3. Pamela G Marrone (Director)
  4. Ozan Pamir (CFO)
Learn More about top insider investors at 180 Life Sciences.
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol